Investor · Malvern, PA

Clay Thorp

Open Clay in the network graph →

Filings

134

SEC Form D

Connections

460

co-filers

Capital

$223.2M

across filings

Active

Jun 2013

to Nov 2025

Most-connected co-filers (460)

John Collins · BUFFALO, NY26 shared Michael Mcqueeney · BUFFALO, NY26 shared Baris Civelek · BUFFALO, NY26 shared Jay Weaver · CHICAGO, IL26 shared Kim Cook · BUFFALO, NY26 shared Christy Shaffer · Research Triangle Park, NC25 shared David N. Abraham · Chicago, IL14 shared Greg N. Dingens · Chicago, IL14 shared Douglas C. Reed · Durham, NC14 shared Daniel N. Kanter · Chicago, IL14 shared Robert Carpenter · Cambridge, MA13 shared Steven E. Hall · Cambridge, MA13 shared Kate Blanchard · Boston, MA13 shared Robert A. Ingram · Durham, NC13 shared Jonathan Y. Meltzer · Boston, MA12 shared Bernard J. Davitian · CAMBRIDGE, MA12 shared Guy K. Fish · Malvern, PA12 shared Doug Y. Jamison · Boston, MA12 shared Carole Neuchterlein · Cambridge, MA11 shared Bruce Booth · Cambridge, MA11 shared Myla V. Lai-Goldman · Durham, NC11 shared Nancy C. Sielaff · MADISON, WI10 shared Conor S. Horrigan · STAMFORD, CT10 shared Christine S. Horrigan · STAMFORD, CT10 shared

Recent filings (134)

PIPr Therapeutics, Inc.Nov 2025 · 5 co-filers$2.5M PIPr Therapeutics, Inc.Nov 2025 · 5 co-filers$2.5M GeneCentric Therapeutics, Inc.Jun 2025 · 18 co-filers$5.0M Hatteras Opportunity Fund I, LPMar 2024 · 19 co-filers$125.0M FRC, INC.Nov 2023 · 8 co-filers$2.0M Hatteras Venture Partners VII, LPSep 2023 · 19 co-filers$250.0M Galileo CDS, Inc.Aug 2023 · 11 co-filers$500K HALF FULL BREWERY, INC.Jul 2023 · 16 co-filers$750K Hatteras Opportunity Fund I, LPFeb 2023 · 22 co-filers$125.0M Hatteras Venture Partners VII, LPFeb 2023 · 22 co-filers$250.0M GeneCentric Therapeutics, Inc.Sep 2022 · 16 co-filers$3.5M Siena Capital Partners I, L.P.Aug 2022 · 10 co-filers HALF FULL BREWERY, INC.Aug 2022 · 16 co-filers$750K MERRITT CAPITAL PARTNERS LPFeb 2022 · 8 co-filers$500.0M Siena Capital Partners Accredited, L.P.Dec 2021 · 13 co-filers Galileo CDS, Inc.Nov 2021 · 11 co-filers$300K FRC, INC.Nov 2021 · 10 co-filers$1.0M GeneCentric Therapeutics, Inc.Oct 2021 · 16 co-filers$7.5M Vigil Neuroscience, Inc.Aug 2021 · 15 co-filers$90.0M Vigil Neuroscience, Inc.Aug 2021 · 15 co-filers$90.0M MERRITT CAPITAL PARTNERS LPJul 2021 · 8 co-filers$500.0M LeasePAL, Inc.Jul 2021 · 2 co-filers$3.5M Vigil Neuroscience, Inc.Jun 2021 · 11 co-filers$50.0M Vigil Neuroscience, Inc.Jun 2021 · 11 co-filers$50.0M PRIMUS CAPITAL FUND IX, LPMay 2021 · 17 co-filers$750.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Clay in the interactive graph →